(Q44132312)

30 November 2017

title

Group III mGlu receptor agonists potentiate the anticonvulsant effect of AMPA and NMDA receptor block (English)

1 reference

30 November 2017

author

Giovambattista De Sarro

series ordinal

1

1 reference

30 November 2017

2

Alba Chimirri

0 references

author name string

Brian S Meldrum

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

European Journal of Pharmacology

30 November 2017

published in

1 reference

30 November 2017

volume

451

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

55-61

1 reference

Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Regulation of neurotransmitter release by metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Potent oral anticonvulsant action of CPP and CPPene in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Anticonvulsant activity of a metabotropic glutamate receptor 8 preferential agonist, (R,S)-4-phosphonophenylglycine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Pharmacology and functions of metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Direct effects of metabotropic glutamate receptor compounds on native and recombinant N-methyl-D-aspartate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Anticonvulsant effects of some calcium entry blockers in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

A note on a simple apparatus for detecting neurological deficit in rats and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Convulsant and anticonvulsant actions of agonists and antagonists of group III mGluRs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

mGluR7-like metabotropic glutamate receptors inhibit NMDA-mediated excitotoxicity in cultured mouse cerebellar granule neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Future prospects for the drug treatment of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Distinct presynaptic metabotropic receptors for L-AP4 and CCG1 on GABAergic terminals: pharmacological evidence using novel alpha-methyl derivative mGluR antagonists, MAP4 and MCCG, in the rat thalamus in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

(S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

Induction or protection of limbic seizures in mice by mGluR subtype selective agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902004-6

10.1016/S0014-2999(02)02004-6

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference